# Minnesota Medical Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/minnesota-medical-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Stewartville, US
- Website: www.mnmedicaltechnologies.com
- Total disclosed funding: $21M
- Latest round: Series A (Mar 5, 2026)
- Investors on record: 2

## About

Minnesota Medical Technologies focuses on developing innovative solutions for managing fecal incontinence, particularly through its flagship product, StaySure™, which enhances users' quality of life by preventing leakage.Minnesota Medical Technologies, headquartered in Stewartville, US, was founded in 2015. The company specializes in advanced solutions for fecal incontinence, distinguishing itself with its flagship product, StaySure™. It has successfully raised USD 20.6 mn in Series A funding from HM Venture Partners and Southeast Minnesota Capital Fund, which will be utilized to support the launch of StaySure™, build sales and support teams, and establish distribution operations. The company has completed one deal, with the most recent funding round occurring on March 5, 2026.Minnesota Medical Technologies specializes in innovative solutions for managing fecal incontinence (FI). Their flagship product, StaySure™, is designed to prevent accidental leakage, offering a proactive approach compared to traditional products that merely absorb waste. Developed with input from top gastroenterologists, StaySure™ enables users to partake in daily activities without the fear of leakage. The product targets individuals suffering from FI and healthcare providers, and is marketed within the United States and select international markets.Minnesota Medical Technologies generates revenue through direct sales of its StaySure™ product to both consumers and healthcare providers. Sales occur through direct-to-consumer channels as well as B2B partnerships with healthcare facilities. Their pricing strategy ensures accessibility for users while accommodating distributors, contributing to ongoing revenue from repeat purchases as customers manage their needs. The company's sales approach prioritizes discretion, aligning with the sensitive nature of fecal incontinence.In March 2026, Minnesota Medical Technologies successfully raised USD 20.6 mn in Series A funding, co-led by HM Venture Partners and Southeast Minnesota Capital Fund. The company plans to use this funding to launch its StaySure™ product in the U.S., enhance sales and support teams, set up distribution operations, and reduce existing debt. Future initiatives include expanding into additional geographic markets, particularly areas with significant populations of older adults or those with gastrointestinal issues.

## Funding rounds

- Series A, Mar 5, 2026, $21M — Southeast Minnesota Capital Fund, HM Venture Partners

## Investors

- Southeast Minnesota Capital Fund (https://capitalatlas.ai/funds/southeast-minnesota-capital-fund) — Series A
- HM Venture Partners — Series A